DEVON, Pa., May 05, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare ...
During the last two decades, CMOS technologists have used scaling to deal with ever-increasing system complexity and performance requirements. Digital abstraction allowed process technology to evolve ...
During the last two decades, CMOS technologists have used scaling to deal with ever-increasing system complexity and performance requirements. Digital abstraction allowed process technology to evolve ...
- Confirmatory pivotal trial expected to be initiated in the third quarter of 2021 - - Zynerba to hold conference call today, May 5, 2021 at 5:30 pm ET - DEVON, Pa., May 05, 2021 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback